A Phase 1b MAD Study of TT301/MW189
Clinical Trial Grant
Administered By
Duke Clinical Research Institute
Awarded By
University of Kentucky
Start Date
January 1, 2017
End Date
June 30, 2019
Administered By
Duke Clinical Research Institute
Awarded By
University of Kentucky
Start Date
January 1, 2017
End Date
June 30, 2019